U
GHDX

UBS’s Genomic Health, Inc. GHDX Stock Holding History

UBS’s Portfolio GHDX Stock Details GHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-100
Closed -$3K – 10979
2014
Q2 		$3K Buy
+100
New +$2.66K ﹤0.01% 9897
2014
Q1 		– Sell
-1,100
Closed -$32K – 11028
2013
Q4 		$32K Buy
+1,100
New +$34.9K ﹤0.01% 7574
2013
Q3 		– Sell
-1,900
Closed -$60K – 10868
2013
Q2 		$60K Buy
+1,900
New +$62.4K ﹤0.01% 6516

Other funds holding GHDX

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
NTC
North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

UBS's GHDX Position: Q2 2014 in Review

UBS sold out of Genomic Health, Inc. (GHDX) in Q2 2014, closing a stake of 2,596 shares — an estimated $69.1K sold.

UBS first reported a position in GHDX in Q2 2013 and held it in 4 quarters. The position peaked at $148K in Q4 2013. 112 funds tracked by Wall St. Rank hold GHDX as of Q2 2014.

  • UBS reported no remaining Genomic Health, Inc. position as of Q2 2014 after selling out during the quarter.
  • UBS sold 2,596 Genomic Health, Inc. shares in Q2 2014, an estimated $69.1K.
  • UBS first reported a position in Genomic Health, Inc. in Q2 2013 and held it in 4 quarters.
  • UBS's Genomic Health, Inc. position peaked at $148K in Q4 2013.
  • 112 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q2 2014.

Based on UBS's 13F filing for Q2 2014, filed 14 Aug 2014.